Search results
Results from the WOW.Com Content Network
Biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) reported fourth-quarter and full-year 2024 earnings on Thursday, Feb. 6, that topped analysts' consensus estimates. Adjusted earnings per ...
Bristol Myers Squibb (NYSE: BMY) Q4 2024 Earnings Call ... Before you buy stock in Bristol Myers Squibb, consider this: ... Our performance in 2024 is marked by focused execution on driving top ...
Bristol-Myers Squibb provides a higher 4.3% yield and an acquisition-driven strategy to counter its 2028 patent cliff. Merck offers a lower but still attractive 3.25% yield, with its specialty ...
Yahoo Finance Live anchors discuss stock performance for Bristol-Myers Squibb amid FDA drug approval.
Bristol Myers Squibb stock has been under pressure because there are aging blockbusters in its product lineup that could lose market share soon. For example, Eliquis is an oral blood thinner that ...
Sure Dividend’s pick for the contest is Bristol-Myers Squibb (NYSE:BMY) stock. Bristol-Myers Squibb (NYSE:BMY) has generated strong total returns of 21% so far in 2022.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey , [ 2 ] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bristol Myers Squibb wasn’t one of them. The 10 stocks that ...